Corindus to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019
March 05 2019 - 6:50AM
Business Wire
Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a
leading developer of precision vascular robotics, today announced
that it will release fourth quarter and full year 2018 financial
and business results on Tuesday, March 12, 2019 after the close of
the U.S. financial markets.
Mark Toland, President and Chief Executive Officer, and David
Long, Chief Financial Officer, will host a conference call to
discuss the results as follows:
Date Tuesday, March 12, 2019 Time 4:30 p.m. EDT Toll
free (U.S.) (833) 286-5802 International (647) 689-4447 Conference
ID: 5572188 Webcast (live and replay)
www.corindus.com under the ‘Investor
Relations’ section.
About Corindus Vascular Robotics, Inc.
Corindus Vascular Robotics, Inc. is a global technology leader
in robotic-assisted vascular interventions. The Company’s CorPath®
platform is the first FDA-cleared medical device to bring robotic
precision to percutaneous coronary and vascular procedures. CorPath
GRX is the second-generation robotic-assisted technology offering
enhancements to the platform by adding important key upgrades that
increase precision, improve workflow, and extend the capabilities
and range of procedures that can be performed robotically. We are
focused on developing innovative robotic solutions to revolutionize
treatment of emergent conditions by providing specialized and
timely medical care to patients around the world. For additional
information, visit www.corindus.com, and follow @CorindusInc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190305005201/en/
Media Contact:Matter for CorindusJessica
Wolter978-518-4536corindus@matternow.comwww.matternow.com
Investor Contact:Lisa WilsonIn-Site Communications, Inc.T:
917-543-9932ir@corindus.com
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jul 2023 to Jul 2024